All data are based on the daily closing price as of December 20, 2024
v
Vuno
338220.KQ
16.50 USD
-0.83
-4.79%
Overview
Last close
16.50 usd
Market cap
229.21M usd
52 week high
49.08 usd
52 week low
16.04 usd
Target price
27.69 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
19.482
Price/Book Value
53.7297
Enterprise Value
229.13M usd
EV/Revenue
13.9545
EV/EBITDA
-9.7142
Key financials
Revenue TTM
11.79M usd
Gross Profit TTM
1.33M usd
EBITDA TTM
-9.56M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
20.21M usd
Net debt
3.68M usd
About
Vuno Inc. operates as a medical artificial intelligence (AI) solution development company. The company provides medical AI solutions for analyzing various medical data and assisting in disease diagnosis. Its products include BoneAge, an AI diagnostic software for bone age assessment; DeepBrain, a brain parcellation for the quantitative analysis of neurodegenerative diseases and other neurological disorders; chest X-ray, a diagnostic support system for abnormalities in chest x-ray; fundus AI, an AI-based screening solution for various abnormalities in the fundus of the eye; and LungCT AI, an AI-based pulmonary lung nodule detection and reporting system. The company was founded in 2014 and is headquartered in Seoul, South Korea.